A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses.

MLA

Guzzo, C. A., et al. “A Review of Two Controlled Multicenter Trials Comparing 0.05% Halobetasol Propionate Ointment to Its Vehicle in the Treatment of Chronic Eczematous Dermatoses.” Journal of the American Academy of Dermatology, vol. 25, no. 6 Pt 2, Dec. 1991, pp. 1179–83. EBSCOhost, https://doi.org/10.1016/0190-9622(91)70322-s.

APA

Guzzo, C. A., Weiss, J. S., Mogavero, H. S., Ellis, C. N., Zaias, N., Lowe, N. J., Kerdel, F. A., Milbauer, J. J., Bernhard, J. D., Whitmore, C., & et. al. (1991). A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses. Journal of the American Academy of Dermatology, 25(6 Pt 2), 1179–1183. https://doi.org/10.1016/0190-9622(91)70322-s

Chicago

Guzzo, C A, J S Weiss, H S Mogavero, C N Ellis, N Zaias, N J Lowe, F A Kerdel, et al. 1991. “A Review of Two Controlled Multicenter Trials Comparing 0.05% Halobetasol Propionate Ointment to Its Vehicle in the Treatment of Chronic Eczematous Dermatoses.” Journal of the American Academy of Dermatology 25 (6 Pt 2): 1179–83. doi:10.1016/0190-9622(91)70322-s.